Loading clinical trials...
Loading clinical trials...
A Phase 1 Randomized, Double-Blinded, Placebo-Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel
Conditions
Interventions
Tenofovir 1% gel
2% N-9 gel
+1 more
Locations
3
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
The Fenway Institute
Boston, Massachusetts, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Start Date
October 1, 2010
Primary Completion Date
July 1, 2011
Completion Date
July 1, 2011
Last Updated
June 28, 2021
Lead Sponsor
CONRAD
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions